MyAmyloidosisTeam

It's still very early to notice changes from Attruby (acoramidis). While this medication was approved in 2023 to treat ATTR cardiomyopathy, improvements typically take time to become noticeable. The medication is designed to be taken once daily as a long-term treatment. Studies show that Attruby can improve heart function Show Full Answer

It's still very early to notice changes from Attruby (acoramidis). While this medication was approved in 2023 to treat ATTR cardiomyopathy, improvements typically take time to become noticeable. The medication is designed to be taken once daily as a long-term treatment. Studies show that Attruby can improve heart function and how people feel in their daily lives over time. Many people taking similar medications like tafamidis have reported improved stamina, better ability to walk, exercise, and manage daily tasks - but these improvements were observed with long-term use.

Continue taking your medication as prescribed and keep track of any changes you notice in your symptoms. Be sure to discuss any concerns about your treatment with your healthcare provider.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

hATTR Amyloidosis Treatments: Comparing Your Options